Stocks
Crescent Biopharma, Inc.CBIO
NASDAQHealthcareBiotechnology$12.36
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel small molecule therapeutics for the treatment of cancer and other serious diseases. Its lead product candidate targets a specific oncogenic pathway, with early-stage clinical trials underway. Investors track the stock for its potential in precision oncology and its pipeline of differentiated drug candidates.
52W Range: $8.72-$27.41
Congressional Interest in Crescent Biopharma, Inc. (CBIO)
No congressional trades have been disclosed for Crescent Biopharma, Inc. (CBIO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CBIO?
No congressional trades found for this stock.